Biomedical Companies

 
Stock Quotes for Biomedical Companies top ^
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for cbat investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for rpbif investment picks
  • Industry: Medical Instruments & Supplies
  • Sector: Healthcare
  • Stock Style: Small Core
  • Stock Type: Distressed
Sign-up for qtxb investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for cbmc investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for rbm investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Growth
Sign-up for 0gn9 investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for sbn investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Distressed
Sign-up for cbmc investment picks
  • Industry: Medical Devices
  • Sector: Healthcare
  • Stock Style: Small Value
Sign-up for rbqp investment picks
  • Industry: Agricultural Inputs
  • Sector: Basic Materials
  • Stock Style: Small Growth
Sign-up for 08189 investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
Sign-up for 2395 investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for entb investment picks

 
News Articles for Biomedical Companies top ^
Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM) (“Enumeral”) today announced the completion of a merger between Enumeral Biomedical Corp.
Sign-up for Enumeral Biomedical Raises $21.5 Million from New and Current Investors, Begins Public Trading investment picks
LANGHORNE, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), today announced the appointment of Andrew Africk and Gary Restani to its Board of Directors.
Sign-up for Alliqua BioMedical Announces Changes to Its Board of Directors investment picks
LANGHORNE, Pa., July 10, 2014 (GLOBE NEWSWIRE) -- David Johnson, Chief Executive Officer of Alliqua Biomedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), has issued the following letter to shareholders: Dear Shareholders, As we move into the second half of 2014, I wanted to update you on Alliqua's progress since my last update earlier in the year, as we are very encouraged by Alliqua's progress during these past six months.
Sign-up for Alliqua BioMedical's CEO Issues Midyear Corporate Update for Shareholders investment picks
Amendment Expands Field of Use for Biovance® to Include Podiatric and Orthopedic Applications LANGHORNE, Pa., Oct.
Sign-up for Alliqua Biomedical Announces Expansion to Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0973079001&sourceType=1 http://media3.marketwire.com/logos/20130306-RESPBIO.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Response Biomedical Corp. Announces Funded Program and Equity Investment by Leading Chinese Medical Device Company investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Biomedical Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Biomarker Research  |  Next: Biomedical Research